News · Brain & Mental Health
Medicare wellness visits raised early memory diagnoses by 28%
Researchers matched 66,443 pairs of Texas Medicare patients. Those who took the free annual wellness visit were far likelier to have mild cognitive impairment caught.
Based on a peer-reviewed matched cohort study in the Journal of the American Geriatrics Society
- Researchers matched 66,443 Texas Medicare patients who had an annual wellness visit in 2018 against 66,443 who saw a primary care provider but had no wellness visit, publishing in the Journal of the American Geriatrics Society.
- The two groups looked alike on testing and imaging in the 12 months before the index date, which is what makes the comparison usable.
- Wellness visit patients were 28% more likely to receive a mild cognitive impairment diagnosis.
- There was no increase in dementia diagnoses, suggesting the visit catches the earlier stage rather than simply finding more disease.
- Among patients with no prior specialist visit, 39.2% in the wellness visit group had follow-up blood tests, against 31.1% in the comparison group.
- Brain imaging did not differ meaningfully (12.4% versus 13.1%), so scans were not the mechanism.
- Only 14% of the extra diagnoses were explained by the follow-up blood tests; the rest came from the visit itself.
- Observational and restricted to Texas fee-for-service Medicare. Matching reduces but does not eliminate the difference between people who take up a free visit and people who do not.
The Medicare annual wellness visit is free, includes a cognitive assessment, and is skipped by a large share of the people entitled to it. A study in the Journal of the American Geriatrics Society asked what difference attending actually makes, and found it changes what gets found.
The authors note that no previous research has examined the extent to which healthcare interventions/services (specific blood tests, specialist referrals, and brain imaging) conducted after annual wellness visits (AWVs) contribute to subsequent MCI/ADRD diagnosis. MCI here means mild cognitive impairment; ADRD covers Alzheimer’s disease and related dementias.
Building a fair comparison
The design problem is obvious. People who show up for a free preventive appointment are not a random sample of anybody.
The researchers handled it by matching. Their comparison group was Texas fee-for-service Medicare enrollees who received a Primary Care Provider visit, but without AWVs in 2018, with 66,443 people in each group.
That choice matters. The comparison is not wellness visit against no healthcare. It is wellness visit against seeing a primary care doctor anyway. The question becomes narrow and useful: does this specific appointment add anything to ordinary care?
The matching appears to have worked. Both groups had similar proportions of patients receiving specific blood tests, specialist referrals, and brain images in the 12 months before AWV/index date. Before the visit, the two groups were being investigated at the same rate.
What changed afterwards
Blood testing diverged. Among those with no previous specialist visits, 39.2% in the AWV group and 31.1% in the non-AWV group received laboratory testing in the follow-up period.
The tests in question were the ones that check for reversible causes of confusion: vitamin B12 and thyroid function. An eight-point gap.
Imaging did not diverge. Among those with no previous brain images, 12.4% in the AWV group and 13.1% in the non-AWV group received brain images - if anything, marginally fewer scans in the wellness visit group.
The diagnosis result
AWV receipt was associated with a 28% increase in MCI diagnosis.
And then the finding that gives the first one its meaning: AWV receipt was not associated with an increase in ADRD diagnosis.
Read together, those two say something specific. The wellness visit is not manufacturing diagnoses across the board. Full dementia gets recognized whether or not someone attends a preventive appointment, because by then it is hard to miss. Mild cognitive impairment is the stage that slips past a normal consultation, and that is the one the visit caught.
Where the extra diagnoses came from
The researchers then tested whether the follow-up blood tests explained the effect. Mostly, they did not: 14% of this increase was explained through post-AWV laboratory testing.
Fourteen percent through labs. The other 86% came from something else, and the authors are direct about what. Medicare AWV had a large direct effect on MCI diagnosis, suggesting that cognitive assessment and clinical evaluations during AWV directly contributed to the early recognition of MCI.
The assessment itself did the work. Not the tests it triggered, not the scans, not the referrals. Somebody sat down and checked.
What the study cannot settle
Matching narrows the gap between the groups; it does not close it. People who take up a free preventive visit may be more health-engaged, better supported, or more likely to mention a memory lapse when asked. Those differences do not show up in claims data, and they could produce part of this result.
The sample is also Texas fee-for-service Medicare, which excludes Medicare Advantage enrollees and everyone in other states. Diagnosis rates vary by region and by how doctors are paid.
The study also measures diagnoses, not health. Nobody was followed to see whether earlier recognition improved anything for the patients concerned. Earlier identification is widely accepted as valuable, and it remains an assumption this particular analysis does not test.
Why it still matters
Mild cognitive impairment is badly under-diagnosed, and it is the stage where the most can still be done, including finding the treatable things that imitate it. An intervention that lifts detection by more than a quarter, through a conversation rather than a scan, in an appointment that already exists and already costs the patient nothing, is an unusually cheap piece of public health.
The barrier is not the technology. It is that many people never book it.
People also ask
What is a Medicare annual wellness visit?
A free yearly appointment available to Medicare enrollees, separate from a regular check-up for a specific complaint. It includes a health risk assessment, a review of medications and, importantly here, a cognitive assessment. It is preventive rather than diagnostic by design, and uptake has historically been well below what is available.
What is mild cognitive impairment?
A stage where memory or thinking is measurably worse than expected for someone's age but daily life is still largely intact. It is not dementia. Some people with it stay stable for years, some improve when a reversible cause is treated, and some progress. That variability is precisely why catching it matters: it is the window in which reversible causes can still be found.
Why is finding more diagnoses a good thing?
Because the alternative is not the absence of the condition, it is the condition going unrecognized. Mild cognitive impairment is substantially under-diagnosed, and the earlier it is identified the more options remain, including treating thyroid problems, vitamin deficiencies, medication side effects and depression, all of which can mimic or worsen it. Earlier recognition also gives families time to plan.
What does it mean that dementia diagnoses did not rise?
It suggests the wellness visit is doing what it was designed for rather than simply generating more labels. Dementia is advanced enough that it tends to get noticed regardless of whether someone attends a preventive appointment. Mild cognitive impairment is subtle enough to slip past an ordinary consultation. The visit moved the needle on the one that hides, and not on the one that does not.
Should someone book an annual wellness visit because of this?
This is general information rather than medical advice, and the visit is already available at no cost to Medicare enrollees. What this study adds is evidence that the cognitive assessment component detects something real. Anyone worried about their memory, or a family member's, should raise it with a clinician directly rather than waiting for an annual appointment to surface it.
References
- Kuo YF, Tzeng HM, Shan Y, Jang JH, Cram P, Raji MA. Association Between Annual Wellness Visits and Early Dementia Diagnoses: Roles of Post-Visit Healthcare Decisions. Journal of the American Geriatrics Society (2026).
- National Institute on Aging. What Is Mild Cognitive Impairment?
- Medicare.gov. Yearly Wellness Visits.